Literature DB >> 8176214

The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site.

J Müllberg1, W Oberthür, F Lottspeich, E Mehl, E Dittrich, L Graeve, P C Heinrich, S Rose-John.   

Abstract

Like many proteins with a single transmembrane domain the IL-6R exists in a membrane-associated and soluble form. The soluble IL-6R is generated by limited proteolysis of the membranous receptor. This process, also called shedding, is drastically enhanced by PMA, an activator of protein kinase C. The soluble receptor protein was purified to homogeneity from supernatants of COS-7 cells transfected with a cDNA coding for the transmembrane IL-6R. The COOH-terminus of the shed receptor protein was analyzed by carboxypeptidase treatment and subsequent amino acid analysis. The established cleavage site Gln357/Asp358 was extensively altered by point mutations and small deletions to define the structural requirements for cleavage. Although point mutations around the cleavage site reduced shedding of the IL-6R up to fivefold, deletions of 5 or 10 amino acids almost completely abolished shedding. Deletion of the cytoplasmic domain of the receptor had no influence on shedding of the protein. It turned out that a potential N-glycosylation site close to the proteolytic cleavage site of the IL-6R is used. However this N-glycosylation does not affect the efficiency of the shedding process. Furthermore, we demonstrate for the first time that the human IL-6R is constitutively phosphorylated and that this phosphorylation can be stimulated by PMA but is not correlated with shedding of the receptor protein. The knowledge of the mechanism by which the soluble IL-6R is generated will help to identify the processing enzyme involved and to analyze its regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8176214

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  79 in total

1.  An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.

Authors:  Owen W Stephens; Qing Zhang; Pingping Qu; Yiming Zhou; Shweta Chavan; Erming Tian; David R Williams; Joshua Epstein; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2011-11-09       Impact factor: 22.113

Review 2.  Interleukin-6 and insulin sensitivity: friend or foe?

Authors:  A L Carey; M A Febbraio
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

Review 3.  Molecular and cellular mechanisms of ectodomain shedding.

Authors:  Kazutaka Hayashida; Allison H Bartlett; Ye Chen; Pyong Woo Park
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

4.  A common variant of the interleukin 6 receptor (IL-6r) gene increases IL-6r and IL-6 levels, without other inflammatory effects.

Authors:  S Rafiq; T M Frayling; A Murray; A Hurst; K Stevens; M N Weedon; W Henley; L Ferrucci; S Bandinelli; A-M Corsi; J M Guralnik; D Melzer
Journal:  Genes Immun       Date:  2007-08-02       Impact factor: 2.676

5.  IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.

Authors:  Sarah Y Lee; Irina A Buhimschi; Antonette T Dulay; Unzila A Ali; Guomao Zhao; Sonya S Abdel-Razeq; Mert O Bahtiyar; Stephen F Thung; Edmund F Funai; Catalin S Buhimschi
Journal:  J Immunol       Date:  2011-01-31       Impact factor: 5.422

6.  Altered interleukin-2 receptor alpha-chain is expressed in human T-cell leukaemia virus type-I-infected T-cell lines and human peripheral blood mononuclear cells of adult T-cell leukaemia patients through an alternative splicing mechanism.

Authors:  S Horiuchi; Y Koyanagi; Y Tanaka; M Waki; A Matsumoto; Y W Zhou; M Yamamoto; N Yamamoto
Journal:  Immunology       Date:  1997-05       Impact factor: 7.397

7.  Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.

Authors:  Michelle Dang; Nicole Armbruster; Miles A Miller; Efrain Cermeno; Monika Hartmann; George W Bell; David E Root; Douglas A Lauffenburger; Harvey F Lodish; Andreas Herrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

8.  Interleukin-6 receptor gene 48892 A/C polymorphism is associated with metabolic syndrome in female Taiwanese adolescents.

Authors:  Chang-Hsun Hsieh; Yi-Jen Hung; Ling-I Wu; Chih-Tsueng He; Chien-Hsing Lee; Fone-Ching Hsiao; Nain-Feng Chu
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-24

Review 9.  Mendelian randomization in cardiometabolic disease: challenges in evaluating causality.

Authors:  Michael V Holmes; Mika Ala-Korpela; George Davey Smith
Journal:  Nat Rev Cardiol       Date:  2017-06-01       Impact factor: 32.419

10.  High-level production of alternatively spliced soluble interleukin-6 receptor in serum of patients with adult T-cell leukaemia/HTLV-I-associated myelopathy.

Authors:  S Horiuchi; W Ampofo; Y Koyanagi; A Yamashita; M Waki; A Matsumoto; M Yamamoto; N Yamamoto
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.